Erik Arstad
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: February 24, 2026
An improved fully-automated GMP radiosynthesis of [18F]fluoro-pivalic acid with solid-phase extraction purification.
Journal: EJNMMI radiopharmacy and chemistry
Published: February 02, 2026
Adrenal Aldosterone Synthase Expression Imaging in Primary Aldosteronism.
Journal: The New England journal of medicine
Published: November 26, 2025
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.
Journal: Brain : a journal of neurology
Published: July 01, 2025
A hybrid [18F]fluoropivalate PET-multiparametric MRI to detect and characterise brain tumour metastases based on a permissive environment for monocarboxylate transport.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 17, 2024
A new model measuring bacterial phagocytosis and phagolysosomal oxidation in humans using the intradermal injection of methylene blue-labeled Escherichia coli.
Journal: Journal of leukocyte biology
Published: July 30, 2024
Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Journal: Journal of neuroinflammation
Published: March 21, 2023
Oxidation-Cyclisation of Biphenyl Thioethers to Dibenzothiophenium Salts for Ultrarapid 18F-Labelling of PET Tracers.
Journal: International journal of molecular sciences
Published: October 28, 2022
Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies.
Journal: Molecular neurodegeneration
Published: January 24, 2022
Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous in vivo delivery of tyrosine kinase inhibitors and kinase activity biosensors.
Journal: Nanoscale
Published: November 03, 2021
Development of [18F]AldoView as the First Highly Selective Aldosterone Synthase PET Tracer for Imaging of Primary Hyperaldosteronism.
Journal: Journal of medicinal chemistry
Published: June 17, 2021
Validation of a combined image derived input function and venous sampling approach for the quantification of [18F]GE-179 PET binding in the brain.
Journal: NeuroImage
Published: December 20, 2020
Last Updated: 09/26/2026